InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Discover the detailed record of transactions filed by Mehta Vimal, CEO, Président et secrétaire. Officer active across 1 companies, notably BioXcel Therapeutics, Inc.. In total, 2 reports have been logged. Total volume traded: €24.5m. The latest transaction was disclosed on 25 June 2021 — Cession. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations2 total
€12m473,250 shares@ €25.8403100.0% of flow
Common Stock
SEC:0001104659-21-086948·
€12m473,250 shares@ €25.840339.62% mcap50.0% of flow
Common Stock
SEC:0001104659-21-086948:0·
2 of 2 declarations
About Mehta Vimal
Vimal Mehta is the CEO, President, and Secretary of BioXcel Therapeutics, Inc. He is responsible for the strategic and operational direction of the company, aiming to ensure its growth and profitability.
